Since the Supreme Court's 2017 sea change venue decision in TC Heartland v. Kraft Food Group Brands, the Northern District of West Virginia has seen an uptick in substantive Hatch-Waxman.
2022 was a milestone year for the Patent Trial and Appeal Board. In April, Kathi Vidal began her tenure as Director of the United States Patent and Trademark Office with an early focus.
Case Name: Bausch Health Ireland, Ltd. v. Padagis Israel Pharms., Ltd., Civ. No. 20-5426 (SRC), 2022 WL 1606961 (D.N.J. May 20, 2022) (Chesler, J.) Drug Product and Patent(s)-in-Suit:.
Case Name: Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., No. 21-10403 (SRC) (JSA), 2022 WL 683084 (D.N.J. Mar. 8, 2022) (Chesler, J.) Drug Product and Patent(s)-in-Suit: Trulance®.
A New Jersey federal judge on Tuesday dismissed several Mylan entities from a patent suit relating to their purported plans to market generic versions of gastrointestinal drug Trulance, while also tossing a number of patent claims and sending the remainder to West Virginia federal court.